Safety and preclinical results coming in the next 1-3 months. Results for phase 2 are in early 2026. Won’t be in it for the efficacy results as the drug class even having 50 percent pre clinical success in primates and 40-50 percent in rodents both showed zero efficacy in humans. But keep being a troll with your posts because you still haven’t given evidence on any evidence the drug class in previous studies has showed even 1 percent of efficacy. Please provide to have a genuine discussion about this
AGN Media thread, page-213
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.5¢ |
Change
0.010(1.36%) |
Mkt cap ! $95.42M | |||
| Open | High | Low | Value | Volume |
| 75.8¢ | 77.5¢ | 74.5¢ | $61.58K | 81.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 74.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |